title: Rivaroxaban for thromboprophylaxis in a patient receiving electroconvulsive therapy.
authors.affiliation: Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Pharmacy Practice College of Pharmacy Rosalind Franklin University North Chicago, IL Michael.Shuman@rosalindfranklin.edu Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Pharmacy Practice Chicago College of Pharmacy Midwestern University Downers Grove, IL Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Psychiatry and Behavioral Sciences Chicago Medical School Rosalind Franklin University North Chicago, IL Captain James A. Lovell Federal Health Care Center North Chicago, IL.
authors.forename: Michael
authors.initials: M
authors.lastname: Shuman
authors.forename: Robin
authors.initials: R
authors.lastname: Hieber
authors.forename: Lori
authors.initials: L
authors.lastname: Moss
authors.forename: Dimple
authors.initials: D
authors.lastname: Patel
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000150:complications / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects* / Q000379:methods; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069552:Rivaroxaban / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban